Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-024013
Filing Date
2024-03-19
Accepted
2024-03-19 16:05:53
Documents
59
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2023_relmadatherap.htm   iXBRL 10-K 934524
2 CONSENT OF MARCUM LLP f10k2023ex23-1_relmada.htm EX-23.1 2352
3 CERTIFICATION f10k2023ex31-1_relmada.htm EX-31.1 11588
4 CERTIFICATION f10k2023ex31-2_relmada.htm EX-31.2 11076
5 CERTIFICATION f10k2023ex32-1_relmada.htm EX-32.1 4812
6 CERTIFICATION f10k2023ex32-2_relmada.htm EX-32.2 4977
  Complete submission text file 0001213900-24-024013.txt   4604930

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rlmd-20231231.xsd EX-101.SCH 45634
8 XBRL CALCULATION FILE rlmd-20231231_cal.xml EX-101.CAL 27340
9 XBRL DEFINITION FILE rlmd-20231231_def.xml EX-101.DEF 213951
10 XBRL LABEL FILE rlmd-20231231_lab.xml EX-101.LAB 418668
11 XBRL PRESENTATION FILE rlmd-20231231_pre.xml EX-101.PRE 210028
63 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023_relmadatherap_htm.xml XML 380824
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39082 | Film No.: 24763060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)